Suresh M. Kumar, Ph.D.
- Center for Cancer Research
- National Cancer Institute
RESEARCH SUMMARY
Dr. Suresh Kumar has been working in the fields of cell and molecular biology of neuroendocrine and endocrine malignancies and developing novel preclinical research tools for rare cancers. Dr. Kumar has made a significant contribution to the field of cancer research and regenerative medicine. His primary research interest and expertise focus on the establishment of patient-derived cancer organoids for drug screening applications, tumor microenvironments, and drug resistance.
Areas of Expertise
Suresh M. Kumar, Ph.D.
Research
Dr. Suresh Kumar's primary research interest and expertise focus on the molecular mechanism behind tumor microenvironment, drug resistance, and cancer metastasis.
Publications
A Combinatorial Strategy for Targeting BRAF V600E Mutant Cancer with BRAF V600E inhibitors (PLX4720) and Tyrosine Kinase Inhibitors (Ponatinib)
Transcriptional alterations in hereditary and sporadic nonfunctioning pancreatic neuroendocrine tumors according to genotype
Acquired cancer stem cell phenotypes through Oct4-mediated dedifferentiation.
Biography
Suresh M. Kumar, Ph.D.
Dr. Suresh Kumar has been working in the fields of cell and molecular biology of neuroendocrine and endocrine malignancies and developing novel preclinical research tools for rare cancers. Dr. Kumar has made a significant contribution to the field of cancer research and regenerative medicine. His primary research interest and expertise focus on the establishment of patient-derived cancer organoids for drug screening applications, tumor microenvironments, and drug resistance.